PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725)  is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D and commercial production. Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of novel building blocks for drug discovery use. Upon daily monitoring recent researches and patents in drug R&D and medicinal chemistry, the product portfolio keeps expanding.With more drug R&D projects applying the company’s products advance from discovery to preclinical and clinical research, even into commercialization, PharmaBlock moved on to build up top notch process R&D capabilities, and is providing scale-up synthesis and manufacturing of building blocks and GMP/non-GMP intermediates.